Evidence map›Paper›PMID 34449548›Full record

ArticleCurrent issues in molecular biology2021

Prostate Apoptotic Induction and NFκB Suppression by Dammarolic Acid: Mechanistic Insight into Onco-Therapeutic Action of an Aglycone Asiaticoside.

Ahmed Alafnan, Talib Hussain, Syed Mohd Danish Rizvi, Afrasim Moin, Abdulwahab Alamri

Open access · goldAbstract read
In one paragraph

Article in Current issues in molecular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ahmed AlafnanDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Hail, Hail P.O. Box 2240, Saudi Arabia.ORCID 0000-0001-7883-1021
Talib HussainDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Hail, Hail P.O. Box 2240, Saudi Arabia.
Syed Mohd Danish RizviDepartment of Pharmaceutics, College of Pharmacy, University of Hail, Hail P.O. Box 2240, Saudi Arabia.ORCID 0000-0002-3106-4707
Afrasim MoinDepartment of Pharmaceutics, College of Pharmacy, University of Hail, Hail P.O. Box 2240, Saudi Arabia.
Abdulwahab AlamriDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Hail, Hail P.O. Box 2240, Saudi Arabia.
University of Ha'il · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate cancer (PCa) is addressed as the second most common form of onco-threat worldwide and is usually considered as the major cause of mortality in men. Recent times have seen a surge in exploration of plant-derived components for alternative therapeutical interventions against different oncological malignancies. Dammarolic acid or Asiatic acid (AsA) is an aglycone asiaticoside that has been reported for its efficacy in several ailments including cancer. The current study aimed to investigate the anti-proliferative potency of AsA against human prostate cancer PC-3 cells. Purified AsA was diluted and PC-3 cells were exposed to 20, 40, and 80 µM concentration and incubated for 24 h. Post-exposure, PC-3 cells showcased a substantial loss of their viability at 20 µM (

Indexed as

Anti-Infective AgentsApoptosisCaspase 3Cell Line, TumorCell SurvivalHumansMaleNF-kappa BPC-3 CellsPentacyclic TriterpenesProstatic NeoplasmsTriterpenesAnti-Infective Agentsasiatic acidasiaticosideCASP3 protein, humanCaspase 3NF-kappa BPentacyclic TriterpenesTriterpenesanti-proliferativeapoptosisAsiatic acidPC-3 cellprostate cancer

Identifiers

PMID34449548
PMCPMC8928952
OpenAlexW3188785433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.